Trials / Sponsors / Jennifer Woyach
Jennifer Woyach
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization Aplastic Anemia, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | 2020-10-23 |
| Active Not Recruiting | Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia | Phase 1 | 2018-08-16 |
| Completed | Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphoc Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2016-01-12 |
| Completed | Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggre Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma | Phase 1 | 2015-06-09 |